EMEA-002319-PIP01-17-M01

Table of contents

Key facts

Active substance
Rezafungin acetate
Therapeutic area
Infectious diseases
Decision number
P/0395/2021
PIP number
EMEA-002319-PIP01-17-M01
Pharmaceutical form(s)
  • Powder for solution for infusion
  • Age-appropriate dosage form for parenteral use
Condition(s) / indication(s)
Treatment of invasive candidiasis
Route(s) of administration
Intravenous use
Contact for public enquiries
Mundipharma Corporation (Ireland) Limited
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating